Deceptive imprinting: A cosmopolitan strategy for complicating vaccination

Vaccine

Volumn 16, Issue 19, 1998, Pages 1780-1787

  Nara, Peter L ^a   Garrity, Robert ^a  

^a Biological Mimetics Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; GLYCOPROTEIN GP 120; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; VACCINE;

ANTIBODY RESPONSE; ANTIGEN BINDING; ANTIGENICITY; B LYMPHOCYTE; CLONAL ANERGY; CONFERENCE PAPER; CROSS REACTION; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGICAL MEMORY; IMMUNOMODULATION; NONHUMAN; PRIORITY JOURNAL; VACCINATION; VACCINE PRODUCTION;

ADULT; ANIMALS; B-LYMPHOCYTES; GENOMIC IMPRINTING; HIV-1; HUMANS; IMMUNODOMINANT EPITOPES; IMMUNOLOGIC MEMORY; T-LYMPHOCYTES; VACCINATION;

EID: 0032211011     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(98)00168-6     Document Type: Conference Paper

References (80)

1. 1 Sher, A. Vaccination against parasites: Special Problems imposed by the adaptation of parasitic organisms to the host immune response. In: The Biology of Parasitism, Pub. Alan R. Liss, Inc. 1988, 169-182.
2. 2 Briles, D. E. and Davie, J. M. Clonal nature of the immune response. II. The effect of immunization on clonal commitment. J. Exp. Med. 1980, 152, 151-160.
3. 3 Benjamin, D. C., Berzofksky, J. A., East, I. J., Gurd, F. N., Hannum, C., Leach, S. J., Margoliash, E., Michael, J. G., Miller, A., Prager, E. M., Reichlin, M., Sercurz, E. E., Smith-Gill, S. J., Todd, P. E. and Wilson, A. C. The antigenic structure of proteins: a reappraisal. Annu. Rev. Immunol. 1984, 2, 67-101.
4. 4 Kavaler, J., Canton, A. J., Staudt, L. M., Schwartz, D. and Gerhard, W. A set of closely related antibodies dominates the primary antibody response to the antigenic site CB of the A/PR/8/34 Influenza virus hemagglutinin. J. Immunol. 145, 2312-2321.
5. 5 Canton, A. J., Brownlee, G. C., Staudt, L. M. and Gerhard, W. Structural and functional implications of a restricted antibody response to a defined antigenic region on the influenza virus hemagglutinin. EMBO J. 1986, 5, 1577-1587.
6. 6 Francis, T., Jr. Influenza: New acquainiance. Ann. Intern. Med. 1953, 39, 203-221.
7. 7 Fenner, F., McAuslan, B. R., Mims, C. A., Sambrook, J., White, D. O. (Eds.), 1974. Pathogenesis: the immune response. In: The Biology of Animal Viruses, 2nd ed. Academic Press, London, pp. 417-418.
8. 8 Angelova, L. A. and Shvartsman, Y. S. Original antigenic sin to influenza in rats. Immunology 1982, 46, 183-188.
9. 9 Mitchell, G. F. Co-evolution of parasites and adaptive immune responses. Immunol. Today 1991, 12(3), A2-5.
10. 10 Nara, P. L., Goudsmit, J., 1991. Clonal dominance of the neutralizing response to the HIV-1 V3 epitope: evidence for original antigenic sin during vaccination and infection in animals, including humans. In: Lerner, R. A., Ginsberg, H., Chanock, R. M., Brown, F. (Eds.), Vaccines 91. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, pp. 51-58.
11. 11 Nara, P. L., Garrity, R. R. and Goudsmit, J. Neutralization of HIV-1; A paradox of humoral proportions. FASEB J. 1991, 5, 2437-2455.
12. 12 Back, N. K. T., Smit, L., Schutten, M., Nara, P. L., Tersmette, M. and Goudsmit, J. Mutations in human immundeficiency virus type 1 gp41 after sensivity to neutralization by gp120 antibodies. J. Virol. 1993, 67, 6897-6902.
13. 13 Kohler, H., Goudsmit, J. and Nara, P. L. Clonal antibody dominance in HIV-1 infection: cause for a limited and failing immune response to HIV-1 infection and vaccination. J. Acq. Immune Defic. Syndrome 1992, 5, 1158-1168.
14. 14 Kohler, H., Muller, S. and Nara, P. Deceptive imprinting in the immune response against HIV-1. Immunol. Today 1994, 13, 475-478.
15. 15 Muller, S., Nara, P. and D'Amelio, R. et al. Clonal patterns in the human immune response to HIV-1 infection. Int. Rev. Immunol. 1992, 9, 1-13.
16. 16 Nara, P. L., Smit, L. and Dunlop, N. et al. Emergence of viruses resistant to neutralization by V3-specific antibodies in experimental human immunodeficiency virus type 1 IIIB infection of chimpanzees. J. Virol. 1990, 64, 3779-3791.
17. 17 Zhang, L. Q., MacKenzie, P., Cleland, A., Holmes, E. C., Leigh-Brown, A. J. and Simmonds, P. Selection for specific sequences in the external envelope protein of human immunodeficiency virus type I upon primary infection. J. Virol. 1993, 67, 3345-3356.
18. 18 Zhu, T., Mo, H., Wang, N., Nam, D. S., Cho, Y., Koup, R. A. and Ho, D. D. Genotypic and phenotypic characterization of HIV-1 in patients with primary infection. Science 261, 1179-1181.
19. 19 Wolfs, T. F., Zwart, G., Bakker, M. and Gousmit, J. HIV-1 genomic RNA diversification following sexual and parenteral virus transmission. Virology 189, 103-110.
20. 20 Pang, S., Sclesinger, Y., Darr, E. S., Moudgil, T., Ho, D. D. and Chen, I. S. Rapid generation of sequence variation during primary infection. AIDS 1992, 6, 453-460.
21. 21 Wolfs, T. F., Zwart, G., Bahher, M. and Goudsmit, J. HIV-1 genomic RNA diversification following sexual and parental transmission. Virology 1992, 189, 103-110.
22. 22 Pantalero, G., Demarest, J. F. and Soudeyns, H. et al. Major expansion of CD8+ T cells with a predominant VB usage during the primary immune response to HIV. Nature 1994, 370, 463-467.
23. 23 Kalams, S. A., Johnson, R. P. and Trocha, A. K. et al. Longitudinal analysis of the T cell receptor (TCR) gene usage by humnan immunodeficiency virus 1 envelope-specific cytotoxic T lymphocyte clones reveals a limited TCR repertoire. J. Exp. Med. 1994, 179, 1261-1271.
24. 24 Schnittman, S., Lane, H., Higgins, S. and Folks, T. Direct polyclonal activation of human B lymphocytes by the acquired immune deficiency syndrome virus. Science 1986, 233, 1084-1088.
25. 25 Martinez-Maza, O., Crabb, E., Mitsuyasu, R. T., Fahey, J. L. and Giorgi, J. V. Infection with human immunodeficiency virus (HIV) is associated with an increase in B lymphocyte activation and immaturity. J. Immunol. 1987, 138, 3720-3724.
26. 26 Briault, S., Courtois-Capella, M., Duarter, F., Aucouturier, P. and Preud'Homme, J. L. Isotypy of serum monoclonal immunoglobulins in human immunodeficiency virus-infected adults. Clin. Exp. Immunol. 1988, 74, 182-184.
27. 27 Ng, V. L., Hwang, K. M. and Reyes, G. R. et al. High titer anti-HIV antibody reactivity associated with a paraprotein spike in a homosexual male with AIDS related complex. Blood 1988, 71, 1397-1401.
28. 28 Amadori, A. and Chieco-Bianchi, L. B cell activation and HIV infection: protective or potentially detrimental response?. Int. Rev. Immunol. 1992, 9, 15-24.
29. 29 Lane, H. C. Masur, H., Edgar, L. C., Whalen, G., Rook, A. H. and Pauci, A. S. Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome. N. Engl. J. Med. 1983, 309, 453.
30. 30 Birx, D. L., Redfield, R. R. and Tosato, G. Defective regulation of Epstein-Barr virus infection in patients with acquired immunodeficiency syndrome (AIDS) or AIDS-related disorders. N. Engl. J. Med. 1986, 314, 874.
31. 31 Berberian, L. Immunoglobulin VH3 gene products: natural ligands for HIV gp120. Science 1993, 261(5128), 1588-1591.
32. 32 Silverman, G. J. and Kohler, H. Clonal restriction in human antibody responses to infections. Int. Rev. Immunol. 1992, 9, 1-57.
33. 33 Langone, J. J. Protein A of Staphylococcus aureus and related immunoglobulin receptors produced by streptococci and pneumonococci. Adv. Immunol. 1982, 32, 157-252.
34. 34 Harboe, M. Recognition of two distinct groups of human IgM and IgA based on different binding to staphylococci. Scand. J. Immunol. 1974, 3(4), 471-482.
35. 35 Inganas, M. Comparison of mechanisms of interaction between protein A from Staphylococcus aureus and human monoclonal IgG, IgA and IgM in relation to the classical FC gamma and the alternative F(ab′)2 epsilon protein A interactions. Scand. J. Immunol. 1981, 13(4), 343-352.
36. 36 Silverman, G. J. Superantigens and the spectrum of unconventional B-cell antigens. Immunologist 1994, 2(2), 51-57.
37. 37 Schechter, I. Antigenic competition between polypeptidyl determinants in normal and tolerant rabbits. J. Exp. Med. 127, 237.
38. 38 Albright, J. F., Omer, T. F. and Deitchman, J. W. Antigenic competition: Antigens compete for a cell occurring with limited frequency. Science 1970, 167, 196.
39. 39 Moller, G. and Sjoberg, O. Effect of antigenic competition on antigen-sensitive cells and on adoptively transferred immunocompetent cells. Cell Immunol. 1970, 1(1), 110-121.
40. 40 Waterson, R. H. Antigenic competition: a paradox. Science 1970, 170, 1108.
41. 41 Radovick, J. and Talmadge, D. W. Antigenic competition: cellular or humoral. Science 1967, 158, 512.
42. 42 Kittlesen, D. J., Brown, L. R., Braciale, V. L., Sambrook, J. P., Gething, M.-J. and Braciale, T. J. Presentation of newly synthesized glycoproteins to CD4+ T lymphocytes. An analysis using influenza hemagglutinin transport mutants. J. Exp. Med. 1993, 177, 1021-1030.
43. 43 Kakiuchi, T., Watanabe, M., Hozumi, N. and Nariuchi, H. Differential sensitivity of specific and nonspecific antigen-presentation by B cells to a protein synthesis inhibitor. J. Immunol. 1990, 145(6), 1653-1658.
44. 44 Lorenz, R. G., Blum, J. S. and Allen, P. M. Constitutive competition by self proteins for antigen presentation can be overcome by receptor-enhanced uptake. 1990, 144, 1600.
45. 45 Rowley, D. A. and Stach, R. M. A first or dominant immunization. I. Suppression of simultaneous cytolytic T cell responses to unrelated alloantigens. J. Exp. Med. 1993, 178(3), 835-840.
46. 46 Lin, Y. A. and Stavnezer, J. Regulation of transcription of the germ-line Ig alpha constant region by an ATF element and by novel transforming growth factor-beta 1 responsive elements. J. Immunol. 1992, 149, 2914.
47. 47 Kuruvilla, A. P., Shah, R., Hochwald, G. M., Liggitt, H. D., Palladino, M. A. and Thorbecke, G. J. Protective effect of transforming growth factor beta 1 on experimental autoimmune diseases in mice. Proc. Natl. Acad. Sci. U. S.A. 1991, 88(7), 2918-2921.
48. 48 Sonoda, E., Matsumoto, R. and Hitoshi, Y. et al. Transforming growth factor beta induces IgA production and acts additively with interleukin 5 for IgA production. J. Exp. Med. 1989, 170(4), 1415-1420.
49. 49 Veenhoff, E. and Seijen, H. G. Plasma cells and their precursors I. Pre-existent antibody-forming cell precursors dominate the anti-sheep red blood cell and anti-human gamma globulin IgG antibody response. Immunobiol. 1982, 162, 165-174.
50. 50 Sharon, R., McMaster, P. R.B., Kask, A. M., Owens, J. D. and Paul, W. E. DNP-Lys-Ficoll: a T-independent antigen which elicits both IgM and IgG anti-DNP antibody-secreting cells. J. Immunol. 1975, 114, 1585.
51. 51 Kunkl, A. and Klaus, G. G.B. The generation of memory cells. V. Preferential priming of IgG1 B memory cells by immunization with antigen IgG2 antibody complexes. Immunology 1981, 44, 163.
52. 52 Mosier, D. E., Johnson, B. M., Paul, W. E. and McMaster, P. R.B. Cellular requirements for the primary in vitro antibody response to DNP-Ficoll. J. Exp. Med. 1974, 139, 1354.
53. 53 Rude, E., Wrede, J. and Gundelach, M. L. Production of IgG antibodies and enhanced response of nude mice to DNP-AE-Dextran. J. Immunol. 1976, 116, 527.
54. 54 Humbert, J., Motta, I. and Truffa-Bachi, P. TNP-LPS induces an IgG anti-TNP immune response in mice. Cell. Immunol. 1979, 47, 211.
55. 55 Colle, J.-H., LeMoal, M. A. and Truffa-Bachi, P. Immunological memory. Crit. Rev. Immunol. 1990, 10, 270-288.
56. 56 Launois, P., Maillard, I. and Pingel, S. et al. IL-4 rapidly produced by Vβ4 VαB CD4+ T cells instructs Th2 development and susceptibility to Leishmania major in Balb/c mice. Immunity 1997, 6, 541-549.
57. 57 Julia, V., McSorley, S., Malherbe, L., Breittmayer, J-P., Girard-Pipau, F., Beek, A., Glaichenhaus, N. A critical role for the intestimal flora in murine Leirhmaniasis. (In preparation).
58. 58 Kalyanaraman, V. S., Pal, R., Gallo, R. C. and Sarngadharan, G. A unique human immunodeficiency virus culture secreting soluble gp160. AIDS Res. Hum. Retroviruses 1988, 4, 319-329.
59. 59 Kalyanaraman, V. S., Rodriguez, V. and Veronese, F. et al. Characterization of the secreted, native gp120 and gp160 of the human immunodeficiency virus type 1. AIDS Res. Hum. Retroviruses 1990, 6, 371-380.
60. 60 Van Cott, T. C., Veit, S. C.D., Kalyanaraman, V., Earl, P. and Birx, D. L. Characterization of a soluble, oligomeric HIV-1 gp160 protein as a potential immunogen. J. Immunol. Methods 1995, 183, 103-117.
61. 61 Nara, P. L., Van Cott, T. C., Brix, D., 1997. Evidence for a primary IgG response to the oligomeric form of gp160 during primary HIV-1 infection in both chimpanzees and humans. In: Brown, F., Burton, D., Doherty, P., Mekalanos, J., Norrby, E. (Eds.), Vaccines 97. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, pp. 331-337.
62. 62 Arthur, L. A., Bess, J. W. Jr. and Waters, D. J. et al. Challenge of chimpanze (Pan troglodytes) immunized with human immunodeficiency virus envelope glycoprotein, gp120. J. Virol. 1989, 63, 5046-5053.
63. 63 Garrity, R. R., Rimmelzwaan, G., Minassian, A., Tsai, W-P., Lin, G., de Jong, J-J., Goudsmit, J. and Nara, P. L. Refocusing Neutralizing antibody response by targeted dampening of an immunodominant epitope. J. Immunol. 159, 279-289.
64. 64 Race, E. M., Ramsey, K. M., Lucia, H. L. and Cloyd, M. W. Human immunodeficiency virus elicits antibody not detected by standard tests: implications for diagnostics and viral immunology. Virology 1991, 184, 716-722.
65. 65 Moore, J. P., Cao, Y., Ho, D. D. and Koup, R. A. Development of the anti-gp120 antibody response during seroconversion to human immunodeficiency virus type 1. J. Virol. 1994, 68, 5142-5155.
66. 66 Nair, B. C., Ford, G., Kalyanaraman, V. S., Zafari, M., Fang, C. and Sarngadharan, M. G. Enzyme immunoassay using native envelope glycoprotein (gp160) for detection of human immunodeficiency virus type 1 antibodies. J. Clin. Microbiol. 1994, 32(6), 1449-1456.
67. 67 Zubler, R. H., Perrin, L. H., Doucet, A., Zhang, X., Huang, Y.-P. and Miescher, P. A. Frequencies of HIV-reactive B cells in seropositive and seronegative individuals. Clin. Exp. Immunol. 1991, 87, 31-36.
68. 68 Davis, D., Chaudhri, B., Stephens, D. M., Carne, C. A., Willers, C. and Lachmann, P. J. The immunodominance of epitopes within the transmembrane protein (gp41) of human immunodeficiency virus type 1 may be determined by the host's previous exposure to similar epitopes on unrelated antigens. J. Gen. Virol. 1990, 71, 1975-1983.
69. 69 Gonzalez-Scarano, F., Waxham, M. N., Ross, A. M. and Hoxie, J. A. Sequence similarities between human immunodeficiency virus gp41 and paramyxovirus fusion proteins. AIDS Res. Hum. Retroviruses 1987, 3, 245-252.
70. 70 Sundquist, V.-A., Linde, A. and Kurtu, R. et al. Restricted IgG subclass responses to HTLV III/LAV and to cytomegalovirus in patients with AIDS and lymphadenopathy syndrome. J. Infect. Dis. 1986, 153, 970-973.
71. 71 Mathiesen, T., Chiodl, F. and Broliden, P.-A. et al. Analysis of a subclass-restricted HIV-1 gp41 epitope by omission peptides. Immunology 1989, 67, 1-7.
72. 72 Mathiesen, T., Sonnerborg, A., von Sydow, M., Gaines, H. and Wahren, B. IgG subclass reactivity against human immunodeficiency virus (HIV) and cytomegalovirus in cerebrospinal fluid and serum from HIV-infected patients. J. Med. Virol. 1988, 25, 17-26.
73. 73 Sayre, K. R., Dodd, R. Y., Tegtmeier, G., Layug, L., Alexander, S. S. and Busch, M. P. False-positive human immunodeficiency virus type 1 Western blot tests in noninfected blood donors. Transfusion 1996, 36, 45-52.
74. 74 Ezekowitz, R. A.B., Kuhlman, M., Groopman, J. E. and Byrn, R. A. A human serum mannose-binding protein inhibits in vitro infection by the human immunodeficiency virus. J. Exp. Med. 1989, 169, 185-196.
75. 75 Tomiyama, T., Lake, D., Masuho, Y. and Hersh, E. M. Recognition of human immunodeficiency virus glycoproteins by natural anti-carbohydrate antibodies in human serum. Biochem. Biophys. Res. Commun. 1991, 177, 279-285.
76. 76 Hansen, J.-E. S., Clausen, H. and Nielsen, C. et al. Inhibition of human immunodeficiency virus (HIV) infection in vitro by anticarbohydrate monoclonal antibodies: peripheral glycosylation of HIV envelope glycoprotein gp120 may be a target for virus neutralization. J. Virol. 1990, 64, 2833-2840.
77. 77 Stach, R. M. and Rowley, D. A. A first or dominant immunization. II. Induced immunoglobulin carries transforming growth factor (and suppresses cytolytic T cell responses to unrelated alloantigens. J. Exp. Med. 1993, 178, 841-852.
78. 78 Vijayakrishnan, L., Kumar, V., Agrewala, J. N., Mishra, G. C. and Rao, K. V.S. Antigen-specific early primary humoral responses modulate immunodominance of B cell epitopes. J. Immunol. 1994, 153, 1613.
79. 79 Gill, S. J., Todd, P. E. and Wilson, A. C. The antigenic structure of proteins: a reappraisal. Annu. Rev. Immunol. 1984, 2, 67-101.
80. 80 Julia, V., Rassoulzadegan, M. and Glaichenhaus, N. Resistance to Leishmania major induced by tolerance to single antigen. Science 1996, 274, 421-423.